{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Ft Lauderdale",
      "address_1": "1458 NW 23rd Ave",
      "reason_for_recall": "Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.",
      "address_2": "",
      "product_quantity": "",
      "code_info": "All lots",
      "center_classification_date": "20140320",
      "distribution_pattern": "Nationwide and France",
      "state": "FL",
      "product_description": "Silver Sword capsules, 180 mg, 16-count clamshell tin, UPC 1 234658 970128  12345   (labeling is in foreign language)",
      "report_date": "20140326",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Fabscout Entertainment, Inc",
      "recall_number": "D-1170-2014",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "product_type": "Drugs",
      "event_id": "65892",
      "termination_date": "20191002",
      "more_code_info": "",
      "recall_initiation_date": "20130627",
      "postal_code": "33311-5147",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}